Rankings
▼
Calendar
INSM Q3 2024 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$93M
+18.2% YoY
Gross Profit
$72M
77.3% margin
Operating Income
-$213M
-228.4% margin
Net Income
-$221M
-236.0% margin
EPS (Diluted)
$-1.27
QoQ Revenue Growth
+3.4%
Cash Flow
Operating Cash Flow
-$181M
Free Cash Flow
-$185M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$2.1B
Total Liabilities
$1.6B
Stockholders' Equity
$483M
Cash & Equivalents
$461M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$93M
$79M
+18.2%
Gross Profit
$72M
$62M
+15.9%
Operating Income
-$213M
-$148M
-44.5%
Net Income
-$221M
-$159M
-38.8%
Geographic Segments
UNITED STATES
$67M
72%
JAPAN
$21M
22%
Europe And The Rest Of The World
$6M
6%
← FY 2024
All Quarters
Q4 2024 →